Lack of comitogenicity by the peroxisome proliferator hepatocarcinogens, Wy-14,643 and clofibric acidMARSMAN, D. S; SWANSON-PFEIFFER, C. L; POPP, J. A et al.Toxicology and applied pharmacology. 1993, Vol 122, Num 1, pp 1-6, issn 0041-008XArticle

Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643CONWAY, J. G; TOMASZEWSKI, K. E; OLSON, M. J et al.Carcinogenesis (New York. Print). 1989, Vol 10, Num 3, pp 513-519, issn 0143-3334Article

Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using Muta mouse and Big Blue transgenic miceLEFEVRE, P. A; TINWELL, H; GALLOWAY, S. M et al.Human & experimental toxicology. 1994, Vol 13, Num 11, pp 764-775, issn 0960-3271Conference Paper

The nongenotoxic hepatocarcinogen Wy-14,643 is an uncoupler of oxidative phosphorylation in vivoKELLER, B. J; BRADFORD, B. U; MARSMAN, D. S et al.Toxicology and applied pharmacology. 1993, Vol 119, Num 1, pp 52-58, issn 0041-008XArticle

Discordant expression of the cyclin-dependent kinases and cyclins in rat liver following acute administration of the hepatocarcinogen [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY 14,643)RININGER, J. A; WHEELOCK, G. D; MA, X et al.Biochemical pharmacology. 1996, Vol 52, Num 11, pp 1749-1755, issn 0006-2952Article

Initiator-specific promotion of hepatocarcinogenesis by WY-14,643 and clofibrateCATTLEY, R. C; KATO, M; POPP, J. A et al.Carcinogenesis (New York. Print). 1994, Vol 15, Num 8, pp 1763-1766, issn 0143-3334Article

Wy-14,643 stimulates hepatic protein kinase C activityBOJES, H. K; KELLER, B. J; THURMAN, R. G et al.Toxicology letters. 1992, Vol 62, Num 2-3, pp 317-322, issn 0378-4274Article

Decreased hepatocyte growth factor level by Wy-14,643, non-genotoxic hepatocarcinogen in F-344 ratsMOTOKI, Y; TAMURA, H; MORITA, R et al.Carcinogenesis (New York. Print). 1997, Vol 18, Num 7, pp 1303-1309, issn 0143-3334Article

Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643PETERS, J. M; CATTLEY, R. C; GONZALEZ, F. J et al.Carcinogenesis (New York. Print). 1997, Vol 18, Num 11, pp 2029-2033, issn 0143-3334Article

The peroxisome proliferators WY-14,643 and methylclofenapate induce hepatocyte ploidy and alterations and ploidy-specific DNA synthesis in F344 ratsMILLER, R. T; SHAH, R. S; CATTLEY, R. C et al.Toxicology and applied pharmacology. 1996, Vol 138, Num 2, pp 317-323, issn 0041-008XArticle

Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replicationWADA, N; MARSMAN, D. S; POPP, J. A et al.Fundamental and applied toxicology (Print). 1992, Vol 18, Num 1, pp 149-154, issn 0272-0590Article

Induction of replicative DNA synthesis and PPARα-dependent gene transcription by Wy-14 643 in primary rat hepatocyte and non-parenchymal cell co-culturesKARAM, W. G; GHANAYEM, B. I.Carcinogenesis (New York. Print). 1997, Vol 18, Num 11, pp 2077-2083, issn 0143-3334Article

Inhibition of intercellular communication of rat hepatocytes by nafenopin : involvement of protein kinase CLEIBOLD, E; GREIM, H; SCHWARZ, L. R et al.Carcinogenesis (New York. Print). 1994, Vol 15, Num 6, pp 1265-1269, issn 0143-3334Article

TFGα is differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotionMILLER, R. T; CATTLEY, R. C; MARSMAN, D. S et al.Carcinogenesis (New York. Print). 1995, Vol 16, Num 1, pp 77-82, issn 0143-3334Article

Peroxisome proliferator-activated receptor α (PPAR α) agonist, WY-14,643, increased transcription of myosin light chain-2 in cardiomyocytesHAMANO, Takako; KOBAYASHI, Kiyoshi; SAKAIRI, Tetsuya et al.Journal of toxicological sciences. 2001, Vol 26, Num 5, pp 275-284, issn 0388-1350Article

Induction of coagulation effects by Wyeth-14,643 in CRL:CD®BR ratsHURTT, M. E; ELLIOTT, G. S; COOK, J. C et al.Drug and chemical toxicology (New York, NY. 1978). 1997, Vol 20, Num 1-2, pp 1-10, issn 0148-0545Article

Effect on the expression of c-met, c-myc and PPAR-α in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643MILLER, R. T; GLOVER, S. E; STEWART, W. S et al.Carcinogenesis (New York. Print). 1996, Vol 17, Num 6, pp 1337-1342, issn 0143-3334, 5 p.Article

Effect of some peroxisome proliferators on transforming growth factor-β₁ gene expression and insulin-like growth factor II/mannose-6-phosphate receptor gene expression in rat liverRUMSBY, P. C; DAVIES, M. J; PRICE, R. J et al.Carcinogenesis (New York. Print). 1994, Vol 15, Num 2, pp 419-421, issn 0143-3334Article